Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Single-armed Trial That Aims to Evaluate the Safety and Efficacy of Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System

NCT03788590 is registered in ClinicalTrials.gov with Ningbo Jenscare Biotechnology Co., Ltd. as lead sponsor.

NCT NCT03788590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03788590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Single-armed Trial That Aims to Evaluate the Safety and Efficacy of Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
Lead sponsor
Ningbo Jenscare Biotechnology Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
February 23, 2019
Completion date
December 30, 2021
Enrollment
133 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, severe aortic stenosis